Small-Cap Momentum Watch: Upcoming Catalysts for June 8–12
6/7/202610 min read
From operational updates to conference participation, we’ve highlighted the small-cap events that could drive attention this week.
--
Companies Presenting at the American Diabetes Association (ADA) 86th Scientific Sessions 2026
The American Diabetes Association (ADA) 86th Scientific Sessions will take place June 5–8, 2026, at the Ernest N. Morial Convention Center in New Orleans, Louisiana. The conference is one of the largest global diabetes meetings, bringing together researchers, clinicians, and industry leaders to present new data and advances in diabetes care, obesity, metabolic disease, and related therapies.
LXRX – will present clinical data on sotagliflozin in Type 1 diabetes and pilavapadin in diabetic peripheral neuropathic pain, including inTandem trial analyses and Phase 1 pharmacokinetic data.
SABS – will deliver an oral presentation on SAB-142, covering clinical safety, pharmacokinetics, immunogenicity, and pharmacodynamic findings in new-onset Type 1 diabetes.
GCTK – will present its fully implantable continuous blood glucose monitoring technology at the ADA Innovation Hub, highlighting direct blood measurement, multi-year implant longevity, and no on-body wearable.
MTVA – will present three late-breaking abstracts on DA-1726 and vanoglipel, covering obesity, glycemic control, weight-loss, and liver health data.
IPSC – will deliver an oral presentation on CNTY-813, its Allo-Evasion™ 5.0-engineered iPSC-derived beta islet replacement therapy for Type 1 diabetes.
BMEA – will present clinical and translational data on icovamenib, including insulin secretion, glycemic control, fat reduction, and lean mass preservation findings.
ELDN – will present updated investigator-initiated trial results on anti-CD40L therapy in islet allotransplantation, focused on graft survival and function.
MNKD – will present new clinical and real-world data on Afrezza® inhaled insulin and FUROSCIX®, including data following Afrezza’s pediatric approval for ages six and older.
Companies Participating at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
The Goldman Sachs 47th Annual Global Healthcare Conference will take place June 8–10, 2026, in Miami, Florida. The conference is one of the healthcare sector’s premier investor events, bringing together executives, institutional investors, and industry leaders to discuss clinical developments, business strategy, market trends, and investment opportunities across biotechnology, pharmaceuticals, medical devices, healthcare services, and life sciences.
QTRX, GERN, ALT, PGEN, DCGO, FHTX, RXRX, EMBC, CMPX, RCKT, SANA, ABSI, PRME, CTMX, MYGN, FATE, ALVO, CCCC
Companies Participating at the Small Cap Showcase & WTR Insights 2026
The Small Cap Showcase & WTR Insights 2026 will take place June 9, 2026, in New York City. The event is a curated investor forum for micro- and small-cap companies, featuring company presentations, one-on-one investor meetings, guest speakers, and networking opportunities.
BESS, OBAI, SCNX, EPM, VTIX
Companies Presenting at the EHA 2026 Congress
The European Hematology Association (EHA) 2026 Congress will take place June 11–14, 2026, in Stockholm, Sweden. EHA is recognized as Europe's premier hematology meeting, bringing together researchers, clinicians, and industry leaders to showcase the latest advances in blood cancers, cellular therapies, immunotherapy, and hematologic disorders.
CRBU – will deliver two oral presentations. The first will feature Phase 1 ANTLER data for vispa-cel in relapsed/refractory B-cell non-Hodgkin lymphoma on Friday, June 12, 2026, from 5:15–6:30 p.m. CEST. The second will provide Phase 1 CaMMouflage follow-up data for CB-011 in relapsed/refractory multiple myeloma on Sunday, June 14, 2026, from 11:00 a.m.–12:15 p.m. CEST.
CLLS – will present data from two allogeneic CAR-T programs. The oral presentation for lasme-cel / UCART22 from the BALLI-01 trial in relapsed/refractory CD22+ B-cell ALL is scheduled for Saturday, June 13, 2026, from 5:15–6:30 p.m. CET. The poster presentation for eti-cel / UCART20x22 from the NATHALI-01 trial in relapsed/refractory B-cell NHL is scheduled for Saturday, June 13, 2026, from 6:45–7:45 p.m. CET.
CCCC – will present a poster with updated data from its Phase 1 trial evaluating cemsidomide in combination with dexamethasone in relapsed/refractory multiple myeloma during EHA 2026, taking place June 11–14, 2026.
EVAX – will present new preclinical data on EVX-04, its AI-designed off-the-shelf therapeutic vaccine for acute myeloid leukemia (AML), highlighting the functional characterization of the program as it advances toward planned clinical testing. The poster presentation will showcase EVX-04’s ability to target endogenous retroviral antigens in AML and represents another step toward the company's planned clinical trial application in the second half of 2026. The presentation is scheduled for Saturday, June 13, 2026, from 6:45–7:45 p.m. CET (12:45–1:45 p.m. ET) during Poster Session 2.
Companies Participating at the Jefferies Innovative Aerospace Virtual Summit 2026
The Jefferies Innovative Aerospace Virtual Summit is scheduled for June 8, 2026. The virtual event will feature fireside chats, one-on-one investor meetings, and discussions focused on aerospace innovation, defense technology, autonomous delivery, intelligent infrastructure, and related growth opportunities.
ARAI, SRFM, HOVR
Other Companies with Material Events This Week:
STTK – Hosting an investor call and webcast on June 8, 2026, at 8:00 a.m. ET to present comprehensive Phase 1 clinical data for SL-325, including safety, tolerability, pharmacokinetics, receptor occupancy, pharmacodynamic, and immunogenicity results. Management will also provide a pipeline update followed by a Q&A session.
CTKB – Participating at CYTO 2026 in West Palm Beach, Florida, June 6–10, 2026, where it will debut its new 7-laser Cytek Borealis full spectrum flow cytometer and showcase automation-ready Aurora Evo systems. The company will host tutorial sessions on June 8 and June 9 focused on flow cytometry innovation and cloud-based workflow solutions.
AREC – Participating in multiple industry events including the Global Industrials Forum in New York City on June 8, 2026, the Battery and Universal Waste Recycling Conference in Nashville on June 8–9, 2026, and the Atlantic Council Global Energy Forum in Washington, D.C. on June 9–10, 2026, with executives attending panels, meetings, and discussions focused on critical minerals, recycling, and energy infrastructure.
INO – Participating in the World Orphan Drug Congress in Boston with a poster presentation titled “Rare Disease Protein Replacement Therapeutics: The Transformational Potential of Next-Gen DNA Medicine” on June 11, 2026, at 12:00 p.m. ET.
IVVD – Participating in the H.C. Wainwright HCW @ Home Series with a virtual fireside chat on June 8, 2026, at 10:00 a.m. ET.
RZLV – Presenting a peer-reviewed research paper on AI-powered commerce and recommendation accuracy at ACM UMAP 2026 in Gothenburg, Sweden, June 8–11, 2026, highlighting developments in agentic commerce and AI transaction systems.
MTVA – Presenting a corporate update on its obesity and metabolic disease pipeline at the Emerging Growth Conference on June 11, 2026, at 3:25 p.m. ET.
HYPD – Participating in ETHConf 2026 in New York City, June 8–10, 2026, a major blockchain and Web3 developer conference.
ZENA – Exhibiting at the Future Force Capabilities Conference & Exhibition 2026 in Las Vegas, Nevada, June 8–10, 2026, where its ZenaDrone division will showcase autonomous drone technologies and engage with military and defense industry leaders.
CLDI – Participating in a RedChip investor webinar on June 9, 2026, at 4:15 p.m. ET, where management will discuss the RedTail targeted virotherapy platform, progress of lead candidate CLD-401, recent preclinical data, and upcoming development milestones.
AMBP – Participating in the Wells Fargo 16th Annual Industrials & Materials Conference in Chicago with a fireside chat on June 9, 2026.
CDIO – Participating in the Conner Strong & Buckelew Health & Benefits Innovation Summit in Philadelphia on June 9, 2026, and the Midwest Employee Benefit Funds Coalition Annual Meeting in Illinois on June 12, 2026.
SBC – Presenting at the Emerging Growth Conference 93 on June 11, 2026, at 9:40 a.m. ET.
ALLO – Participating in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference on June 9, 2026.
SKYX – Showcasing and promoting its smart electrical technologies through licensing partner Eurofase at the Hotel & Cruise Ship Expo in Miami on June 9–10, 2026, targeting hospitality and commercial building markets.
BMR – Presenting its ML-safe video data stack for autonomous vehicles at AutoSens USA 2026 in Detroit, June 9–11, 2026, focusing on AI-enabled data solutions for AV and ADAS applications.
TBLA – Participating in the Rosenblatt Age of AI Conference with a fireside chat on June 9, 2026, at 10:00 a.m. ET.
CMND – Hosting a live webinar titled “Inside MEAI: Exclusive Investigator Q&A with Yale & Johns Hopkins” on June 10, 2026, from 12:00–1:00 p.m. EDT, featuring discussion of clinical data from its ongoing Phase I/IIa trial evaluating CMND-100 for Alcohol Use Disorder.
NWTG – Presenting at the Emerging Growth Conference on June 11, 2026, at 1:10 p.m. ET, followed by a live Q&A session.
RSSS – Presenting at the East Coast IDEAS Investor Conference in New York on June 10, 2026, at 4:00 p.m. ET, with management also conducting investor meetings.
MSS – CFO Alexandria Lopez has been named a nominee for the 2026 LA Executive Awards. The LA Executive Forum & Leadership Awards will take place on June 8, 2026, in Santa Monica, California.
SABS – Presenting data on SAB-142 at the Federation of Clinical Immunology Societies (FOCIS) Annual Meeting in San Francisco, June 9–12, 2026, highlighting its lead immunotherapy candidate for newly diagnosed Type 1 Diabetes patients.
OVID – Participating in the Oppenheimer CNS & Neuro-Muscular Summit on June 10, 2026, at 3:45 p.m. ET.
LIDR – Showcasing a live intelligent transportation system deployment with the Michigan Department of Transportation at ITS America 2026 in Detroit, June 10–12, 2026, demonstrating its lidar-based traffic monitoring platform.
UIS – Presenting at the East Coast IDEAS Conference in New York on June 10, 2026, at 11:15 a.m. ET.
NSRX – Hosting a virtual KOL event on June 10, 2026, at 8:00 a.m. ET focused on the treatment landscape and unmet needs in anaphylaxis, featuring leading allergy and immunology experts.
NUAI – Participating in the Macquarie AI Infrastructure Conference in New York on June 10, 2026, and the Maxim Group AI Data Center Virtual Summit on June 11, 2026, including a fireside chat.
BZAI – Participating in the D.A. Davidson Technology & Consumer Conference in Nashville on June 10–12, 2026, including a fireside chat on June 11, 2026, at 4:35 p.m. CDT.
GRWG – Participating in Oppenheimer’s 26th Annual Consumer Growth and E-Commerce Conference on June 10, 2026.
ATAI – Participating in the Oppenheimer CNS & Neuro-Muscular Summit on June 10, 2026, including a fireside chat at 1:35 p.m. ET and one-on-one investor meetings.
SABR – Participating in the Bank of America Technology, Media & Telecom Conference with a fireside chat on June 10, 2026, at 10:40 a.m. ET.
COCH – Expected to receive grant approval for European Patent No. 4297862 on June 10, 2026, covering technology related to rechargeable implantable battery systems and thermal management.
EEIQ – Presenting at the Emerging Growth Conference on June 11, 2026, at 9:00 a.m. ET.
NAGE – Presenting at the East Coast IDEAS Investor Conference in New York on June 11, 2026.
AGNT – Participating in the D.A. Davidson Technology & Consumer Conference in Nashville on June 11, 2026, conducting one-on-one investor meetings.
HUMA – Expected to report top-line interim results from its V012 Phase 3 dialysis access study on June 11, 2026, during the Society of Vascular Surgery Vascular Annual Meeting (VAM) in Boston. Positive results could support an sBLA submission in the second half of 2026.
DIBS – Participating in the East Coast IDEAS Investor Conference in New York on June 11, 2026.
ALIT – Participating in the D.A. Davidson Technology & Consumer Conference in Nashville on June 11, 2026, conducting one-on-one investor meetings.
IDN – Participating in the D.A. Davidson Technology & Consumer Conference in Nashville on June 11, 2026, with management hosting one-on-one investor meetings.
HTOO – Holding an Extraordinary General Meeting on June 8, 2026, where shareholders will vote on the proposed Royal Uranium acquisition, conversion of preferred shares, and changing the company name to Fusion Elements plc.
HFFG – Participating in the D.A. Davidson Technology & Consumer Conference in Nashville on June 11, 2026, with management conducting one-on-one investor meetings.
EDIT – Presenting preclinical data at the 2026 National Lipid Association Sessions in Scottsdale, Arizona, June 11–14, 2026, highlighting an in vivo CRISPR gene-editing program designed to reduce LDL-C and Lp(a).
LPCN – Hosting a virtual Key Opinion Leader event on June 12, 2026, at 11:00 a.m. ET, discussing postpartum depression and the clinical profile of LPCN 1154 (BRLIZIO™).
DGNX – Announced that the outside date for its proposed Resulticks acquisition has been extended from May 29, 2026, to June 12, 2026, as closing conditions continue to be finalized.
RZLT – Presenting four abstracts at ENDO 2026 in Chicago, June 13–16, 2026, including an oral presentation of Phase 3 sunRIZE data for ersodetug (RZ358) in congenital hyperinsulinism on June 13, along with multiple poster presentations.
OCGN – Participating in Clinical Trials at the Summit 2026 in Las Vegas on June 13, 2026, with management joining a panel discussion on innovation in inherited retinal diseases.
ENTX – Presenting multiple abstracts at ENDO 2026 in Chicago, June 13–16, 2026, including a late-breaking oral presentation on EB613 supporting Phase 3 development in osteoporosis and additional data on obesity candidate EB618.
ENSC – Participating in the College on Problems of Drug Dependence (CPDD) 88th Annual Meeting in Portland, Oregon, June 13–17, 2026, providing updates on its PF614 and PF614-MPAR programs and development strategy.
MYSE – Exhibiting at the Florida Bridal & Wedding Expo in Fort Lauderdale on June 14, 2026, promoting its Picture Party social media and event-sharing platform.
XOS – Exhibiting at the Government Fleet Expo & Conference (GFX) 2026 in Long Beach, California, June 9–12, 2026, showcasing battery-electric fleet vehicles and mobile energy solutions.
AMBO – Launching the HybriU Partner Portal, an AI-native channel platform for education and event markets, while participating in activities surrounding the AIA Conference on Architecture & Design in San Diego, June 10–13, 2026.
PDC – Presenting at the Emerging Growth Conference on June 10, 2026, at 4:10 p.m. ET, including a live investor Q&A session.
FFAI – Serving as a presenting sponsor at the Summer 2026 Educational Panel & Networking Event in Providence, Rhode Island, on June 11, 2026, with executive presentations and investor engagement.
APM – Extended the merger agreement with DiamiR through June 30, 2026 while continuing efforts to satisfy closing conditions. Following completion, former DiamiR shareholders are expected to own approximately 70% of the combined company, with Aptorum shareholders owning approximately 30%.
--
Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.
Disclaimer: Penny stock trading involves substantial risk, so always research every alert before trading, consult with a licensed professional before trading, only invest what you can afford to lose, and always trade with caution. Readers should independently investigate and fully understand all risks before investing. Results listed are NOT typical and individual results may and most likely will vary. Bigtimepennystocks.com and its staff are NOT licensed investment advisors or broker/dealers of any kind.Alerts are not a solicitation or recommendation to buy/sell/hold securities but merely investment ideas that should NEVER serve as the basis of your trading decisions. Bigtimepennystocks.com and its newsletter are for entertainment purposes only. This website and its reports are for general information purposes as we are engaged in the business of marketing and advertising companies for monetary compensation. Any investment decision should be discussed with a financial adviser before taking place. Please invest carefully and read investment information available at the website of the SEC at http://www.sec.gov.
Subscribe to our Free Newsletter
Copyright © 2023 BigTimePennyStocks.com - All Rights Reserved.